Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversity

Hideki Iwamoto, Shigeo Shimose, Tomotake Shirono, Takashi Niizeki, Takumi Kawaguchi

Clin Mol Hepatol. 2023;29(3):593-604. Published online February 13, 2023

DOI: https://doi.org/10.3350/cmh.2022.0391

View: 3526 Download: 307 Web of Science: 4 Crossref: 5

Editorial

Management of hepatocellular carcinoma in China: Seeking common grounds while reserving differences

Tian Yang, Ming-Da Wang, Xin-Fei Xu, Chao Li, Han Wu, Feng Shen

Clin Mol Hepatol. 2023;29(2):342-344. Published online March 16, 2023

DOI: https://doi.org/10.3350/cmh.2023.0106

View: 2578 Download: 58 Web of Science: 1 Crossref: 2

Review

Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Japanese perspective

Hironori Koga, Hideki Iwamoto, Hiroyuki Suzuki, Shigeo Shimose, Masahito Nakano, Takumi Kawaguchi

Clin Mol Hepatol. 2023;29(2):242-251. Published online March 20, 2023

DOI: https://doi.org/10.3350/cmh.2023.0102

View: 4065 Download: 208 Web of Science: 3 Crossref: 4

Deep learning-based prediction of molecular cancer biomarkers from tissue slides: A new tool for precision oncology

Sung Hak Lee, Hyun-Jong Jang

Clin Mol Hepatol. 2022;28(4):754-772. Published online April 21, 2022

DOI: https://doi.org/10.3350/cmh.2021.0394

View: 4643 Download: 228 Web of Science: 8 Crossref: 7

Optimizing the management of intermediate-stage hepatocellular carcinoma: Current trends and prospects

Takuji Torimura, Hideki Iwamoto

Clin Mol Hepatol. 2021;27(2):236-245. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0204

View: 8107 Download: 373 Web of Science: 40 Crossref: 38

Special topic: Alcoholic liver diseases The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)

Roles of the complement system in alcohol-induced liver disease

Yi Zhou, Guandou Yuan, Fudi Zhong, Songqing He

Clin Mol Hepatol. 2020;26(4):677-685. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0094

View: 6533 Download: 140 Web of Science: 9 Crossref: 11

Review

Hepatitis C virus and hepatocarcinogenesis

Soung Won Jeong, Jae Young Jang, Raymond T. Chung

Clin Mol Hepatol. 2012;18(4):347-356. Published online December 21, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.4.347

View: 13526 Download: 131 Crossref: 66

2

Molecular targeting for treatment of advanced hepatocellular carcinoma

Il Han Song

Clin Mol Hepatol. 2009;15(3):299-308. Published online September 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.3.299

View: 5434 Download: 36 Crossref: 6

Wilson Disease: an Update

Jeong Kee Seo

Clin Mol Hepatol. 2006;12(3):333-363. Published online January 1, 2000

View: 6801 Download: 241

Clinical Experience of Cell-free Liver Support System

Hee Jung Wang,Myung Wook Kim

Clin Mol Hepatol. 2000;6(4):421-424. Published online January 1, 2000

View: 1836 Download: 13

1 |

Viewed By 5300	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5245	MAFLD: How is it different from NAFLD?
Viewed By 5150	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3862	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3800	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search